Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, July 22, 2014
 
Register | Sign in
Home Page>Products
  Product News
Agilent Integrates Sophisticated Target Deconvolution Capabilities into MassHunter Software
Tuesday, June 17, 2014
Robust quantitative/qualitative data easily extracted from complex samples.

Agilent Solutions for SFC with Mass Spectrometric Detection
Tuesday, June 17, 2014
Company’s solutions for supercritical fluid chromatography streamline high-volume analysis of complex compounds.

Novel Microfluidic Droplet-in-Droplet System from Dolomite
Tuesday, June 17, 2014
The Double Emulsion System offers monodisperse double emulsions.

Protea Announces HRAM Analytical Services
Tuesday, June 17, 2014
Adds HRAM to its mass spectrometry based molecular imaging and LC-MS bioanalytical services portfolio.

AB SCIEX StatusScope™ Remote Monitoring Service Enables Trouble-Shooting and Control via Smartphone
Tuesday, June 17, 2014
Sophisticated, User-Configurable Service Minimizes Downtime.

Protea Announces Ion Mobility Mass Spec Imaging Services
Tuesday, June 17, 2014
Ion mobility for metabolite and lipid profiling is added to its mass spectrometry-based molecular imaging services portfolio.

New AB SCIEX Triple Quad™ 3500 System Redefines Simplified Mass Spec
Tuesday, June 17, 2014
New engineering and software deliver significant increase in quantitation and analysis power.

Rigaku Launches the SmartLab 3 System
Tuesday, June 17, 2014
A multipurpose X-ray diffractometer with built-in intelligent guidance.

New 1mL ISOLUTE® SLE+ 48-well Plates from Biotage
Tuesday, June 17, 2014
Enabling the extraction of larger sample volumes, faster! Med chem, proteomics, bioprocessing and screening

<< 9 10 11 12 13 14 15 >>
Showing Results 111 - 120 of 10345
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv